Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
150.95B
Market cap150.95B
Price-Earnings ratio
24.35
Price-Earnings ratio24.35
Dividend yield
2.79%
Dividend yield2.79%
Average volume
11.26M
Average volume11.26M
High today
$87.93
High today$87.93
Low today
$85.81
Low today$85.81
Open price
$86.74
Open price$86.74
Volume
10.25M
Volume10.25M
52 Week high
$139.06
52 Week high$139.06
52 Week low
$81.97
52 Week low$81.97

Stock Snapshot

Abbott(ABT) stock is priced at $86.81, giving the company a market capitalization of 150.95B. It carries a P/E multiple of 24.35 and pays a dividend yield of 2.8%.

As of 2026-05-27, Abbott(ABT) stock has fluctuated between $85.81 and $87.93. The current price stands at $86.81, placing the stock +1.2% above today's low and -1.3% off the high.

Abbott(ABT) shares are trading with a volume of 10.25M, against a daily average of 11.26M.

In the last year, Abbott(ABT) shares hit a 52-week high of $139.06 and a 52-week low of $81.97.

In the last year, Abbott(ABT) shares hit a 52-week high of $139.06 and a 52-week low of $81.97.

ABT News

Simply Wall St 4d
Abbott Deepens Digital Health Push With New Cardiovascular Diagnostics And Wearables

Abbott Laboratories (NYSE:ABT) is expanding further into health technology with new diagnostics and wearables, including its Lingo biomarker device. The compan...

Abbott Deepens Digital Health Push With New Cardiovascular Diagnostics And Wearables
Nasdaq 7d
Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum

Abbott’s ABT Established Pharmaceuticals Division (“EPD”) has remained a steady growth driver, delivering above 7% sales growth for the past several quarters. I...

Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum

Analyst ratings

77%

of 31 ratings
Buy
77.4%
Hold
22.6%
Sell
0%

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.